Skip to main content
. 2020 Sep 28;23(1):75–85. doi: 10.1111/dom.14189

FIGURE 1.

FIGURE 1

Patient flow‐chart of patients with type 2 diabetes without cardiovascular or renal disease. DPP4i, dipeptidyl peptidase‐4 inhibitor; SGLT2i, sodium‐glucose cotransporter‐2 inhibitor